Skip to main content

Table 3 Multivariate analysis for overall survival (OS) and progression-free survival (PFS)

From: Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation

Variable OS PFS
  HR 95 % CI p HR 95 % CI p
A-ALC ≥ 0.5 × 109/kg 0.401 0.231–0.972 0.04 0.439 0.271–0.902 0.03
A-AMC < 0.6 × 109/kg 0.502 0.100–0.985 0.04 0.490 0.288–0.911 0.03
A-LMR ≥ 1 0.258 0.105–0.561 <0.001 0.298 0.112–0.482 <0.001
CR prior to APHSCT 0.356 0.166–0.731 0.005 0.401 0.211–0.681 0.008
Hemoglobin < 12 g/dl     1.592 0.861–2.935 0.1
IPI > 2 2.377 1.163–4.972 0.02 1.398 0.705–2.771 0.3
Platelet < 150 × 109/l 1.297 0.627–2.607 0.5 1.164 0.590–2.268 0.7
  1. Abbreviations: A-ALC autograft absolute lymphocyte count, A-AMC autograft absolute monocyte count, A-LMR autograft lymphocyte/monocyte ratio, A-LMR autograft lymphocyte/monocyte ratio, CR complete response, IPI International Prognostic Index, LDH lactate dehydrogenase